SAN DIEGO, Nov. 28, 2017 -- Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the U.S., announced today that subsidiary HempMeds® was a Gold Sponsor of EXPO MEDE Weed, the second International Fair of Medical Cannabis, which took place in Medellín, Colombia on November 24-27, 2017.
This conference is organized annually to discuss the legality of medical cannabis globally. Currently in Colombia, non-psychotropic Cannabis (Hemp) is legal to grow if it contains less than 1% THC.
At the conference, executives from the Medical Marijuana, Inc. portfolio of companies spoke to hundreds of patients and doctors at the event about CBD and shared stories of previous international successes in Mexico, Brazil and Paraguay. Speakers included Dr. Stuart Titus, CEO of Medical Marijuana, Inc., and Raul Elizalde, President of HempMeds® Mexico.
"We are proud to sponsor this global event and speak with an international audience about our products and the benefits of CBD," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We are working to bring HempMeds® to Colombia in 2018."
Those interested in learning more about HempMeds® and its products are encouraged to visit https://hempmedspx.com.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
Public Relations Contact:
Chief Executive Officer
P. 888-829- 0070